---
title: Eosinophilic Gastrointestinal Disorders Patient Registry
nct_id: NCT01779154
overall_status: WITHDRAWN
sponsor: "Arkansas Children's Hospital Research Institute"
study_type: OBSERVATIONAL
primary_condition: Eosinophilic Esophagitis
countries: United States
canonical_url: "https://parkinsonspathways.com/agent/trials/NCT01779154.md"
clinicaltrials_gov: "https://clinicaltrials.gov/study/NCT01779154"
ct_last_update_post_date: 2016-06-20
last_seen_at: "2026-05-12T07:06:56.985Z"
source: ClinicalTrials.gov (mirrored, no enrichment)
---
# Eosinophilic Gastrointestinal Disorders Patient Registry

**NCT ID:** [NCT01779154](https://clinicaltrials.gov/study/NCT01779154)

## Key Facts

- **Status:** WITHDRAWN
- **Why Stopped:** funding not available
- **Study Type:** OBSERVATIONAL
- **Target Enrollment:** 0
- **Lead Sponsor:** Arkansas Children's Hospital Research Institute
- **Conditions:** Eosinophilic Esophagitis, Eosinophilic Gastritis, Eosinophilic Enteritis, Eosinophilic Colitis
- **Start Date:** 2013-01
- **Completion Date:** 2017-05
- **CT.gov Last Update:** 2016-06-20

## Brief Summary

The Eosinophilic Gastrointestinal Disorders (EGIDS) Registry is a longitudinal study that does not involve medical interventions, but serves as a record of demographics, characteristics of disease and treatment, utilization patterns, quality improvement measures and clinical outcomes. The database is proposed so that epidemiologic research can be performed and current and accurate data can be obtained regarding practice patterns, age and gender distributions, efficacy of treatment, clinical outcomes and changes in quality of life.

## Eligibility

- **Maximum age:** 21 Years
- **Sex:** ALL
- **Healthy Volunteers:** No

```
Inclusion Criteria:

* male or female participants of any race or ethnicity
* age 0 to 21 years
* diagnosis of EGID including: eosinophilic esophagitis, eosinophilic gastritis, eosinophilic enteritis, eosinophilic colitis

Exclusion Criteria:

* hypereosinophilic syndrome
* non-eosinophilic gastrointestinal or allergic disorder
```

## Arms

- **eosinophilic gastrointestinal disorders** — Individuals with a diagnosis of EGID including: eosinophilic esophagitis, eosinophilic gastritis, eosinophilic enteritis, eosinophilic colitis

## Primary Outcomes

- **To define characteristics of an eosinophilic gastrointestinal disorder population in a rural southern state** _(time frame: After 12 months of data collection)_ — To develop a database of patients with eosinophilic gastrointestinal disorders so that epidemiologic research can be performed and current data can be obtained regarding practice patterns, age and gender distributions, efficacy of treatment, clinical outcomes and changes in quality of life.

## Locations (1)

- Arkansas Children's Hospital, Little Rock, Arkansas, United States

## Recent Field Changes (last 30 days)

- `status.overallStatus` — added _(2026-05-12)_
- `status.whyStopped` — added _(2026-05-12)_
- `status.primaryCompletionDate` — added _(2026-05-12)_
- `status.completionDate` — added _(2026-05-12)_
- `status.lastUpdatePostDate` — added _(2026-05-12)_
- `design.enrollmentCount` — added _(2026-05-12)_
- `eligibility.criteria` — added _(2026-05-12)_
- `eligibility.maxAge` — added _(2026-05-12)_
- `eligibility.sex` — added _(2026-05-12)_
- `outcomes.primary` — added _(2026-05-12)_
- `armsInterventions.arms` — added _(2026-05-12)_
- `sponsor.lead` — added _(2026-05-12)_
- `results.hasResults` — added _(2026-05-12)_
- `locations.arkansas children's hospital|little rock|arkansas|united states` — added _(2026-05-12)_

---

*Canonical: https://parkinsonspathways.com/agent/trials/NCT01779154.md*  
*Source data (authoritative): https://clinicaltrials.gov/study/NCT01779154*  
*This page is a raw mirror with no AI summary, no editorial enrichment, and no Parkinson's-specific filtering.*